BioSpace News Archive

RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, announced the election of Peter Svennilson, Managing Partner of The Column Group, to its Board of Directors.

Codagenix, Inc., a clinical-stage biotechnology company developing prophylactic vaccines and oncolytic virus therapies, today announced the successful synthesis of a readily-scalable live-attenuated vaccine candidate against COVID-19. The vaccine, CDX-005, is currently undergoing safety and efficacy studies in animals and appears m

Renovion, Inc., a biopharmaceutical company on a mission to transform the treatment of chronic inflammatory lung diseases, announced completion of a Series A financing round of $8.1 million to fund the development and clinical programs associated with their lead therapeutic candidate ARINA-1. ARINA-1 is a nebulized therapy developed to improve mucus clearance and

Cambrex, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, announced that Tom Loewald has been named Chief Executive Officer and a member of the company’s Board of Directors, effective September 7th.

Urovant Sciences (Nasdaq: UROV) today announced it has entered into an exclusive three-year distribution agreement with Sunovion Pharmaceuticals Inc. (Sunovion) for services to support the commercialization of vibegron, an investigational agent for the treatment of overactive bladder. Both companies are subsidiaries of Sumitomo Dainippon Pharma Co., Ltd. The co-promotion agreement will enable

The reopening of commercial buildings in the wake of COVID-19 poses the unintended risk of Legionnaire’s disease––and Flow-Tech is poised to be a key component of the long-term solution.

While initial hot spots of COVID-19 were centered in dense urban areas, infections have rapidly expanded into suburban and rural settings – in areas with a population between 2,500 and 50,000 according to The Henry J. Kaiser Family Foundation.

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced a collaboration with the American Society of Hematology (ASH), the world’s largest professional society of hematologists, to support a new effort to increase capacity for newborn screening, education, and cli

In what is planned to be an ever-growing resource for laboratory informatics professionals everywhere, CSols, Inc., the premier laboratory informatics consultancy, has launched CSols University, with its first-ever online course, Creating a Lab Informatics Risk Assessment.

Tiziana Life Sciences plc, the U.S. and U.K. biotechnology company that focuses on the discovery and development of novel molecules to treat human disease in oncology and immunology, announces Gregor MacRae is standing down as a director of the Company with immediate effect.